1. Home
  2. ATI vs RGEN Comparison

ATI vs RGEN Comparison

Compare ATI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATI
  • RGEN
  • Stock Information
  • Founded
  • ATI 1960
  • RGEN 1981
  • Country
  • ATI United States
  • RGEN United States
  • Employees
  • ATI N/A
  • RGEN N/A
  • Industry
  • ATI Steel/Iron Ore
  • RGEN Medical/Dental Instruments
  • Sector
  • ATI Industrials
  • RGEN Health Care
  • Exchange
  • ATI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ATI 7.3B
  • RGEN 8.0B
  • IPO Year
  • ATI N/A
  • RGEN N/A
  • Fundamental
  • Price
  • ATI $75.08
  • RGEN $128.04
  • Analyst Decision
  • ATI Strong Buy
  • RGEN Buy
  • Analyst Count
  • ATI 8
  • RGEN 12
  • Target Price
  • ATI $73.29
  • RGEN $172.67
  • AVG Volume (30 Days)
  • ATI 2.4M
  • RGEN 830.2K
  • Earning Date
  • ATI 05-01-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • ATI N/A
  • RGEN N/A
  • EPS Growth
  • ATI 2.35
  • RGEN N/A
  • EPS
  • ATI 2.76
  • RGEN N/A
  • Revenue
  • ATI $4,463,600,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • ATI $7.17
  • RGEN $13.93
  • Revenue Next Year
  • ATI $8.41
  • RGEN $14.35
  • P/E Ratio
  • ATI $27.21
  • RGEN N/A
  • Revenue Growth
  • ATI 6.82
  • RGEN 4.88
  • 52 Week Low
  • ATI $39.23
  • RGEN $102.97
  • 52 Week High
  • ATI $72.28
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • ATI 83.39
  • RGEN 44.98
  • Support Level
  • ATI $51.80
  • RGEN $123.10
  • Resistance Level
  • ATI $75.26
  • RGEN $135.47
  • Average True Range (ATR)
  • ATI 2.50
  • RGEN 6.85
  • MACD
  • ATI 1.73
  • RGEN -0.74
  • Stochastic Oscillator
  • ATI 97.70
  • RGEN 19.54

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: